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C
omputed tomography 
(CT) has been a boon 
for medical care. By 
generating detailed 
anatomical pictures, the 
technology can improve 
diagnoses, limit unneeded medical procedures, 
and enhance treatment. However, CT scans also 
dose patients with ionizing radiation, a known 
human carcinogen, posing a potential downside 
for public health. Mounting health worries over 
radiation risks are now driving efforts to limit 
avoidable CT scans and to reduce radiation 
doses where possible. “There’s a national focus 
on this issue right now,” says Marilyn Goske, a 
professor of radiology at Cincinnati Children’s 
Hospital Medical Center and chairwoman of the 
Image Gently campaign, a pediatric education 
and awareness campaign from the Alliance for 
Radiation Safety in Pediatric Imaging.
In December 2011 the Institute of 
Medicine (IOM) published a report concluding 
that ionizing radiation contributes more to 
the development of breast cancer than any 
other type of routine environmental exposure.
1 
About half the U.S. annual exposure to 
ionizing radiation comes from natural sources, 
including cosmic rays, but most of the rest 
comes from medical imaging and from CT 
scans in particular.
1 The IOM cited research 
by Amy Berrington de González, a senior 
investigator in the Radiation Epidemiology 
Branch of the National Cancer Institute 
(NCI), whose calculations suggest that the CT 
scans performed in the United States in 2007 
might produce up to 29,000 cancers in the 
future, about 6% of them in the breast and the 
remainder in the lungs, brain, and other organs.
2
But the spotlight on CT safety has also 
drawn a backlash from those who say the risks 
are overblown. On 13 December 2011 the 
American Association of Physicists in Medicine 
(AAPM) issued a statement claiming that Spheres of Influence  | CT Scans
risks from CT imaging are “too low to be 
detectible and may be non-existent.”
3 The 
AAPM added that “speculative predictions 
about cancer incidence and death” should be 
discouraged because they generate sensationalist 
media coverage that deters some patients 
who  need  CT  scans  from  having  them. 
Donald Miller, acting chief of the Diagnostic 
Devices Branch of the U.S. Food and Drug 
Administration (FDA) Center for Devices and 
Radiological Health, cites 2 basic principles for 
decreasing CT radiation risks. One is justifica-
tion, which refers to prescribing a CT exam 
only when it is medically necessary. The other is 
optimization, which refers to adjusting and oper-
ating a CT scanner so that images adequate for 
diagnosis are obtained at the lowest possible dose. 
Justification is more difficult to address, Miller 
says, because it involves case-by-case decisions 
made by individual clinicians. More attention 
has been paid to optimization, he says, but both 
principles are equally important. 
Calculating Risks
CT scanners were developed during the 1960s 
by England’s EMI Central Research Labora-
tories. Interestingly, EMI’s parent company 
owned a record label whose superstar act—the 
Beatles—generated funding that helped propel 
CT scanners into routine medical use.4 The 
technology started becoming widespread dur-
ing the 1980s, and uses rose dramatically when 
faster scanning speeds made it possible to image 
large sections of anatomy in seconds. 
An estimated 75 million CT exams were 
performed in the United States in 2009.
5 Vari-
ous estimates suggest that anywhere from 5% 
to 30% of these exams—each costing hundreds 
to thousands of dollars—may be medically 
unnecessary. Why would a clinician request an 
unnecessary scan? In a 2010 perspective article 
Rebecca Smith-Bindman, professor in residence 
at the University of California, San Francisco, 
School of Medicine, explained, “[T]here are few 
evidence-based guidelines regarding their appro-
priate use, and institutional use varies widely, 
reflecting physicians’ preferences and manufac-
turers’ promotion of these capabilities, rather 
than scientific evidence of improved clinical out-
comes. . . . Ironically, technical improvements 
have led to increases in the identification of inci-
dental (and almost certainly irrelevant) findings 
that result in follow-up CT for surveillance.”
5 
CT scanners emit X rays. Different tissue 
types absorb X rays in varying amounts, and 
the resulting contrasts provide detailed imag-
es of anatomy and disease. Absorbed radiation 
can break chemical bonds in tissues, liberating 
charged ions (hence the term “ionizing radia-
tion”) that can damage DNA and produce cancer 
should cells be unable to repair themselves. Non-
ionizing radiation—lower-energy radiofrequency 
waves such as those emitted by microwave ovens 
and cell phones—doesn’t break chemical bonds.
Scientists can’t state conclusively that CT 
scans cause cancer until ongoing prospective 
studies of that link generate results. In the 
meantime, they estimate cancer outcomes 
using dose–response models derived from other 
radiation-exposed groups, such as atomic-bomb 
survivors and patients treated with radiation. 
The dominant risk assessment model appears 
in a 2006 report from the National Research 
Council’s Biological Effects of Ionizing Radiation 
(BEIR) subcommittee.
6 The BEIR VII model 
postulates there is no safe level of ionizing radia-
tion exposure; carcinogenic effects are assumed to 
follow a linear dose response, meaning even the 
smallest exposure carries some level of cancer risk. 
The BEIR VII model generates so-called lifetime 
attributable risk (LAR) factors, which estimate 
the likelihood of cancer in hypothetical individ-
uals as a function of dose. Multiplying the LAR 
by the number of people exposed to a given dose 
yields an estimate of expected cancers from that 
exposure in the population.
Berrington de González relied on BEIR VII 
to derive her estimate of 29,000 additional can-
cers resulting from CT scans performed in 2007.
2 
Likewise, Smith-Bindman used it to estimate that 
1 cancer might appear for every 270 middle-aged 
women who undergo CT coronary angiography, 
a high-dose diagnostic procedure that scans heart 
vessels repeatedly after injection of a contrast 
dye.
7 Young people face especially high risks, 
Smith-Bindman says, in part because they live 
long enough for cancer to develop after a carci-
nogenic exposure. Therefore, she estimates that 
women aged 20 who undergo the same coronary 
procedure have twice the risk as middle-aged 
women.
7 
On the flip side of the risk spectrum, Smith-
Bindman also estimates that 1 cancer could 
appear for every 11,080 men who get a rou-
tine head CT scan.
7 Head scans involve less risk 
in part because they dose a single organ—the 
brain—unlike coronary and abdominal scans 
that dose multiple organs, including the breasts 
and lungs. 
Debating Low-Dose Risks
Radiation’s low-dose effects remain contro-
versial, however, and many experts question 
these high-end risk estimates. John Boice, a 
professor at Vanderbilt University School of 
Medicine, points to a paper published in 2011 
reporting that human cells can efficiently repair 
radiation-induced double-strand DNA breaks.
8 
The paper’s authors claim their findings cast 
doubt on the assumption that risks from ion-
izing radiation are proportional to dose. “And 
that implies that radiation could have a no-
effects threshold,” Boise says. “At the very least 
it suggests that low-dose effects are lesser than 
those predicted from high-dose extrapolation 
based on a linear model.”
Likewise, William Hendee, a professor at the 
Medical College of Wisconsin, who authored the 
AAPM’s position statement on CT risks, argues 
that cancer estimates from CT exposure typically 
draw on worst-case assumptions at every step 
of the process, from expectations of dose linear-
ity to the numbers selected for calculating LARs. 
“Every parameter in the BEIR VII model has a 
distribution of possible values,” he says. “So the 
actual number of predicted cancers could range 
from the highest possible number to zero.”  
Hendee also claims that BEIR VII relies 
excessively on data generated by atom-bomb 
survivors, many of whom suffered from malnutri-
tion, lack of medical care, and other effects result-
ing from the blast, he says. “No one knows the 
cumulative effect of those risks compared with 
the radiation risk,” Hendee says. “And cancer 
incidence differs for Japanese and U.S. cohorts—
more stomach cancer in the Japanese, and more 
breast cancer among Americans, for example—
so the two populations aren’t really comparable.” 
Finally, atom-bomb survivors received instanta-
neous full-body radiation doses of varying mag-
nitude (depending on distance from the blast 
and other factors), Hendee explains, unlike CT 
scan recipients, who get much smaller, targeted 
exposures from imaging. 
The AAPM’s position statement asserts that 
cancer risks are negligible at effective doses below 
50 millisieverts (mSv) for single CT exposures 
and below 100 mSv for multiple exposures over 
short durations. But a 2003 paper coauthored by 
David Brenner, director of the Center for Radio-
logical Research at Columbia University School 
of Public Health, claims that the atom-bomb sur-
vivor data work well for low-dose extrapolation 
because they’re drawn from large cohorts with 
well-defined exposures and complete followup.
9 
And those data, Brenner says, show a statistically 
significant trend of increasing cancer risk with 
increasing organ dose between 5 and 100 mSv. 
Smith-Bindman echoes his conclusions, arguing 
that cancer risks are established even at effective 
doses of 10 mSv.
Estimates of the average effective dose from 
CT scans vary widely. Smith-Bindman’s calcu-
lations, based on data supplied by 6 integrated 
health plans that kept detailed dose information 
for individual patients, indicate that the average 
effective dose of ionizing radiation from medi-
cal imaging per year in the United States was 
6.7 mSv in 2007, most of it from CT.
1 Mean-
while, by dividing the total amount of radiation 
emitted by CT scans in 2006 by the total U.S. 
population, the National Council on Radia-
tion Protection & Measurements calculated a 
much lower average per-capita effective dose of 
3.0 mSv. Miller argues that because it’s based on 
a much broader data set, the council’s estimate is 
more accurate. 
A Data Vacuum
Of course, a single CT scan can deliver doses 
that far exceed these annual averages. For 
instance, Smith-Bindman reported that a CT 
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angiogram can deliver an organ-specific dose to 
the breast of 51 milligrays (mGy)
10 or greater.
7 
But doses per indication vary by institution and 
by the patient’s size, and national averages sim-
ply aren’t available. “If you were to ask, ‘What’s 
the average radiation dose for a head scan in the 
U.S.?’ the answer would be, ‘We don’t know,’” 
says Michael McNitt-Gray, an associate profes-
sor of radiological sciences at the University of 
California, Los Angeles. 
Part of the problem is that radiologists have 
yet to reach a consensus for how to define the 
dose to the patient, he says. Effective and organ-
specific doses both relate to how much radiation 
the body absorbs. But CT scanners don’t report 
the absorbed fraction. Instead, they report only 
what the machine emits, which is less than what’s 
absorbed by the body. One com  monly reported 
value, the computed tomography dose index 
(CTDI), describes the amount of radiation given 
off by the CT scanner during a single scan, or 
“slice.” Another metric—the total dose-length 
product (DLP)—describes the amount of radia-
tion given off for all the slices in a CT sequence 
during an examination. 
These units provide a useful way to compare 
scanner output, but since they don’t describe 
dose, they’re not adequate for risk assessment, 
Miller says. “The real goal is to calculate organ 
doses,” he says. “If we know the organ dose, we 
can do a much better job estimating the indi-
vidual’s cancer risk.” 
The American College of Radiology (ACR) 
and other medical professional organizations 
have recommended “reference levels” for some 
medical imaging exams. Reported as CTDI, 
these levels represent upper-bound radiation 
exposures for specific medical indications that 
shouldn’t be exceeded among individual patients. 
But the reference values aren’t enforced by the 
federal government, whose regulatory authority 
extends only to CT scanner manufacturers, not 
to imaging protocols designed by facilities that 
use the technology. “So you could get a CT scan 
at one hospital, and the radiation dose could be 
ten to a hundred times higher than it would be 
somewhere else,” Smith-Bindman says. 
In 2009, 206 patients at Cedars-Sinai 
Medical Center in Los Angeles accidentally 
received brain-specific overdoses ranging up to 
6,000 mGy while being scanned for suspected 
stroke.
11 Facing litigation, the hospital released 
only limited information about what led to the 
overdoses, claiming they occurred when techni-
cians bypassed the protocol that came installed 
on the machine. In response, California legisla-
tors passed SB 1237,
12 which represents the first 
attempt to require reporting of radiation doses 
from CT in the United States. The law stipulates 
that as of 1 July 2012, California hospitals must 
record in an electronic database the dose (as 
either CTDI or DLP) of every CT scan given. In 
addition, the scanner output must be reviewed 
once a year by a medical physicist. 
Other overdosing episodes have since been 
disclosed elsewhere in the United States, and 
additional states are now considering legislative 
or regulatory changes inspired by the California 
model, according to Ruth McBurney, executive 
director of the Conference of Radiation Con-
trol Directors, based in Frankfurt, Kentucky. 
McBurney said her organization will be surveying 
state initiatives within the next few weeks.
Addressing Problem Areas
The FDA’s main efforts in the area of radia-
tion protection revolve around its Initiative 
to Reduce Unnecessary Radiation Exposure 
from Medical Imaging, which launched in 
2010.
13 Miller says the FDA is making progress 
on the initiative by working with industry on 
new equipment safety features, working with 
AAPM and others to establish “reasonable scan 
protocols and standardize imaging terminol-
ogy,” devising safety checklists for CT opera-
tors, and funding efforts to improve training 
for equipment operators involved in pediatric 
CT imaging, among other activities. 
Meanwhile, the ACR has set out to tackle the 
dose variability problem by creating a national 
registry that allows facilities to upload anony-
mized scan information for different procedures 
into a centralized database. Facilities can check 
their dose values against those of other participat-
ing hospitals as a quality control tool to evaluate 
their own imaging practices and dosing proto-
cols. Over time, the range of doses delivered for 
a given exam should narrow toward an average 
value, according to Richard Morin, the registry’s 
chairman and a professor at the Mayo Clinic 
campus in Jacksonville, Florida.
If there’s a problem with the ACR registry, 
it’s that it only addresses CT optimization, or 
efforts to reduce CT examination doses. In its 
current form it cannot address the broader issue 
of justification, or how clinicians decide if a CT 
scan is medically necessary, Miller says. So in 
December 2011 the FDA partnered with the 
Centers for Disease Control and Prevention to 
sponsor a symposium aimed at investigating 
prospects for a national registry that might tackle 
both these angles.
14 Conclusions from that meet-
ing, which was hosted by the National Academies 
as part of its annual Beebe Symposium, will be 
contained in a forthcoming report, Miller says.
Later in 2012 investigators will release results 
from the first study of CT-related cancer in chil-
dren. Led by the NCI and the University of 
Newcastle, the study follows 200,000 U.K. resi-
dents who received CT scans before the age of 18 
between 1985 and 2008. “We’ve been following 
them for brain cancer and leukemia, which are 
typical childhood cancers,” says Berrington de 
González, the study’s principal investigator at 
the NCI.
According to Berrington de González, doc-
tors in the United Kingdom prescribe about 
7 times fewer CT scans than those in the United 
States, French doctors prescribe 3 times fewer, 
and in Germany, half as many scans are given. 
Asked why, she says, “That’s the million-dollar 
question! It’s not entirely clear, but economic 
incentives and defensive medicine may be some 
of the factors that account for the particularly 
high uses here.” 
Still, Boice points out that CT risks must 
always consider and be balanced against the 
substantial clinical benefits—CT scans can save 
lives by improving diagnoses and even reduce 
some medical costs if they limit unnecessary 
procedures, such as exploratory surgery. What’s 
more, CT technology has been linked to declines 
in cancer mortality, according to the ACR. In 
children, decreases in exploratory surgeries and 
decreased time to triage patients are direct ben-
efits of CT scans. “They’re only a problem if the 
examinations are unnecessary or if the exposures 
are higher than necessary to provide a good clini-
cal image,” Boice says.
“When clinically justified, a CT scan’s ben-
efits always outweigh its associated individual 
risks—whatever they are,” says Brenner. “That 
being said,” he adds, “even when a CT is justi-
fied we should still use the lowest reasonably 
achievable dose for the scan.”
Charles W. Schmidt, MS, an award-winning science writer 
from Portland, ME, has written for Discover Magazine, Science, 
and Nature Medicine.
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